X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (21806) 21806
Newsletter (252) 252
Magazine Article (143) 143
Dissertation (96) 96
Book Chapter (84) 84
Web Resource (15) 15
Conference Proceeding (14) 14
Newspaper Article (14) 14
Publication (7) 7
Book / eBook (3) 3
Government Document (3) 3
Paper (2) 2
Streaming Video (2) 2
Book Review (1) 1
Report (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (12339) 12339
isoniazid (9038) 9038
tuberculosis (6591) 6591
science & technology (6153) 6153
isoniazid - therapeutic use (5910) 5910
male (5744) 5744
life sciences & biomedicine (5442) 5442
female (5225) 5225
old medline (4871) 4871
adult (4345) 4345
isoniazid - pharmacology (3701) 3701
middle aged (3168) 3168
animals (3014) 3014
tuberculosis, pulmonary - drug therapy (2989) 2989
antitubercular agents - therapeutic use (2827) 2827
mycobacterium tuberculosis - drug effects (2764) 2764
isoniazid - administration & dosage (2356) 2356
rifampin - therapeutic use (2356) 2356
niacin (2316) 2316
adolescent (2145) 2145
isoniazid - adverse effects (2034) 2034
abridged index medicus (1863) 1863
drug therapy, combination (1834) 1834
aged (1769) 1769
antitubercular agents - pharmacology (1746) 1746
tuberculosis - drug therapy (1746) 1746
child (1735) 1735
infectious diseases (1709) 1709
streptomycin - therapeutic use (1465) 1465
mycobacterium tuberculosis (1429) 1429
drug resistance, microbial (1366) 1366
drug resistance (1351) 1351
microbiology (1302) 1302
antitubercular agents - administration & dosage (1283) 1283
time factors (1274) 1274
pharmacology & pharmacy (1260) 1260
rifampin (1230) 1230
ethambutol - therapeutic use (1220) 1220
nicotinic acids - therapeutic use (1213) 1213
rifampin - administration & dosage (1201) 1201
isomerism (1171) 1171
rifampin - pharmacology (1132) 1132
mycobacterium tuberculosis - isolation & purification (1080) 1080
research (1047) 1047
microbial sensitivity tests (1046) 1046
respiratory system (1036) 1036
mice (994) 994
drug therapy (974) 974
infant (964) 964
pyrazinamide - therapeutic use (942) 942
antitubercular agents - adverse effects (902) 902
child, preschool (888) 888
rats (886) 886
mycobacterium tuberculosis - genetics (879) 879
tuberculosis - prevention & control (874) 874
antitubercular agents (862) 862
tuberculosis, pulmonary - therapy (854) 854
streptomycin (853) 853
isoniazid - metabolism (813) 813
treatment outcome (794) 794
tuberculin test (748) 748
streptomycin - pharmacology (743) 743
general & internal medicine (710) 710
research article (706) 706
isoniazid - analogs & derivatives (702) 702
mutation (696) 696
nicotinic acids - pharmacology (680) 680
pyrazinamide (677) 677
risk factors (674) 674
chemistry (656) 656
tuberculosis, pulmonary (651) 651
tuberculosis, pulmonary - microbiology (650) 650
immunology (635) 635
rifampin - adverse effects (632) 632
rifampicin (625) 625
aminosalicylic acids - therapeutic use (609) 609
analysis (608) 608
physical sciences (603) 603
medicine, general & internal (594) 594
isoniazid - toxicity (585) 585
guinea pigs (584) 584
aminosalicylic acids (578) 578
bacterial infections and mycoses (576) 576
tuberculosis, pulmonary - prevention & control (573) 573
tuberculosis, multidrug-resistant - drug therapy (568) 568
sputum - microbiology (563) 563
aminosalicylic acid (553) 553
ethambutol - administration & dosage (541) 541
follow-up studies (530) 530
pyrazinamide - administration & dosage (527) 527
young adult (522) 522
health aspects (518) 518
streptomycin - administration & dosage (518) 518
ethambutol (516) 516
medicine (515) 515
drugs (511) 511
isoniazid - blood (503) 503
retrospective studies (490) 490
tuberculosis - epidemiology (489) 489
tuberculosis - microbiology (457) 457
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (16629) 16629
French (1233) 1233
Russian (1195) 1195
German (1117) 1117
Italian (700) 700
Japanese (630) 630
Spanish (539) 539
Polish (361) 361
Portuguese (251) 251
Chinese (131) 131
Hungarian (83) 83
Dutch (66) 66
Romanian (65) 65
Czech (42) 42
Turkish (40) 40
Korean (36) 36
Norwegian (31) 31
Ukrainian (28) 28
Swedish (27) 27
Bulgarian (24) 24
Danish (18) 18
Croatian (15) 15
Hebrew (13) 13
Serbian (11) 11
Finnish (9) 9
Slovak (5) 5
Indonesian (4) 4
Persian (3) 3
Breton (2) 2
Greek (2) 2
Lithuanian (2) 2
Albanian (1) 1
Arabic (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


JAMA pediatrics, ISSN 2168-6203, 01/2015, Volume 169, Issue 3, pp. 247 - 255
Journal Article
by Danel, Christine and Moh, Raoul and Gabillard, Delphine and Badje, Anani and Le Carrou, Jérôme and Ouassa, Timothée and Ouattara, Eric and Anzian, Amani and Ntakpé, Jean-Baptiste and Minga, Albert and Kouame, Gérard M and Bouhoussou, Franck and Emieme, Arlette and Kouamé, Antoine and Inwoley, André and Toni, Thomas-D'Aquin and Ahiboh, Hugues and Kabran, Mathieu and Rabe, Cyprien and Sidibé, Baba and Nzunetu, Gustave and Konan, Romuald and Gnokoro, Joachim and Gouesse, Patrice and Messou, Eugène and Dohoun, Lambert and Kamagate, Synali and Yao, Abo and Amon, Solange and Kouame, Amadou-Barenson and Koua, Aboli and Kouamé, Emmanuel and Ndri, Yao and Ba-Gomis, Olivier and Daligou, Marcelle and Ackoundzé, Simplice and Hawerlander, Denise and Ani, Alex and Dembéle, Fassery and Koné, Fatoumata and Guéhi, Calixte and Kanga, Constance and Koule, Serge and Séri, Jonas and Oyebi, Mykayila and Mbakop, Nathalie and Makaila, Olewole and Babatunde, Carole and Babatounde, Nathanael and Bleoué, Gisèle and Tchoutedjem, Mireille and Kouadio, Alain-Claude and Sena, Ghislaine and Yededji, Sahinou-Yediga and Assi, Rodrigue and Bakayoko, Alima and Mahassadi, Alassane and Attia, Alain and Oussou, Armel and Mobio, Max and Bamba, Doféré and Koman, Mesmin and Horo, Apollinaire and Deschamps, Nina and Chenal, Henri and Sassan-Morokro, Madeleine and Konate, Seidou and Aka, Kakou and Aoussi, Eba and Journot, Valérie and Nchot, Célestin and Karcher, Sophie and Chaix, Marie-Laure and Rouzioux, Christine and Sow, Papa-Salif and Perronne, Christian and Girard, Pierre-Marie and Menan, Hervé and Bissagnene, Emmanuel and Kadio, Auguste and Ettiegne-Traore, Virginie and Moh-Semdé, Corinne and Kouame, Abo and Massumbuko, Jean-Marie and Chêne, Geneviève and Dosso, Mireille and Domoua, Serge K and N'Dri-Yoman, Thérèse and Salamon, Roger and Eholié, Serge P and Anglaret, Xavier and The TEMPRANO ANRS 12136 Study Group and TEMPRANO ANRS 12136 Study Group
The New England journal of medicine, ISSN 1533-4406, 08/2015, Volume 373, Issue 9, pp. 808 - 822
Journal Article
Antimicrobial agents and chemotherapy, ISSN 1098-6596, 05/2012, Volume 56, Issue 5, pp. 2535 - 2545
Journal Article
Clinical infectious diseases, ISSN 1058-4838, 05/2017, Volume 64, Issue 10, pp. 1350 - 1359
Background. There is scant evidence to support target drug exposures for optimal tuberculosis outcomes. We therefore assessed whether... 
pharmacokinetic-pharmacodynamic variability | drug-drug antagonism | minimum inhibitory concentrations | Mycobacterium tuberculosis | tuberculosis treatment outcomes | Infectious Diseases | Immunology | Life Sciences & Biomedicine | Microbiology | Science & Technology | Sputum - microbiology | Tuberculosis, Pulmonary - microbiology | Isoniazid - pharmacology | Rifampin - pharmacokinetics | Rifampin - blood | Coinfection - drug therapy | Humans | Middle Aged | Male | Tuberculosis, Pulmonary - drug therapy | Mycobacterium tuberculosis - drug effects | Tuberculosis, Pulmonary - complications | Microbial Sensitivity Tests | Pyrazinamide - pharmacology | Drug Interactions | Mycobacterium tuberculosis - physiology | Adult | Female | Isoniazid - therapeutic use | Rifampin - therapeutic use | Drug Therapy, Combination | Isoniazid - antagonists & inhibitors | Antitubercular Agents - therapeutic use | Pyrazinamide - administration & dosage | Isoniazid - pharmacokinetics | Pyrazinamide - pharmacokinetics | Antitubercular Agents - pharmacology | Logistic Models | Treatment Outcome | Pyrazinamide - blood | Coinfection - virology | Mycobacterium tuberculosis - isolation & purification | Coinfection - microbiology | Antitubercular Agents - pharmacokinetics | HIV Infections - complications | Rifampin - pharmacology | Mycobacterium tuberculosis - growth & development | Treatment outcome | Care and treatment | Research | Antibiosis | Analysis | Pulmonary tuberculosis | Therapy | Thresholds | Adjustment | Splines | Viruses | Pharmacology | Exposure | Regression analysis | Pyrazinamide | Patients | Conversion | Optimization | Prescription drugs | Antagonism | Tuberculosis | Human immunodeficiency virus--HIV | Sputum | Minimum inhibitory concentration | Nonlinearity | Models | Mathematical models | Isoniazid | Rifampin | Culture | Index Medicus | Major | drug–drug antagonism
Journal Article
The New England journal of medicine, ISSN 1533-4406, 10/2014, Volume 371, Issue 17, pp. 1577 - 1587
Journal Article
The New England journal of medicine, ISSN 1533-4406, 12/2011, Volume 365, Issue 23, pp. 2155 - 2166
Journal Article